{"id":5650,"date":"2014-06-10T09:00:00","date_gmt":"2014-06-10T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/"},"modified":"2024-09-23T11:22:42","modified_gmt":"2024-09-23T11:22:42","slug":"middel-tegen-artritis-vertraagt-ontwikkeling-t1d","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/","title":{"rendered":"Middel tegen artritis vertraagt ontwikkeling T1D!"},"content":{"rendered":"Onderzoek toont aan dat gebruik van het artritismiddel Abatacept de ontwikkeling van Type 1 Diabetes (T1D) kan vertragen, tot een jaar nadat men is gestopt met het nemen van het middel.\n\nHet onderzoek werd uitgevoerd bijmensen die recent de diagnose T1D hadden gekregen. Zij namen het middel gedurende twee jaar in. Abatacept wordt nu gebruikt als ontstekingsremmer bij artritis en heeft een remmende werking op de T-cellen. Dit zijn juist de cellen die de insulineproducerende b\u00e8tacellen in de alvleesklier aanvallen waardoor T1D ontstaat.\n\nHet middel blijft de ontwikkeling van T1D nog een jaar vertragen nadat men gestopt is met de inname ervan. De resultaten van het onderzoek toonden aan dat de C-peptide levels van deze groep hoger waren dan bij mensen die het middel niet hadden gekregen. De C-peptide levels zijn een indicatie voor de hoeveelheid insulineproducerende cellen in de alvleesklier.\n\n<a href=\"http:\/\/www.diabetes.co.uk\/news\/2014\/may\/arthritis-drug-abatacept--slows-type-1-diabetes-progression-96737101.html\">Meer informatie (Engelstalig).<\/a>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Onderzoek toont aan dat gebruik van het artritismiddel Abatacept de ontwikkeling van Type 1 Diabetes (T1D) kan vertragen, tot een jaar nadat men is gestopt met het nemen van het middel. Het onderzoek werd uitgevoerd bijmensen die recent de diagnose T1D hadden gekregen. Zij namen het middel gedurende twee jaar in. Abatacept wordt nu gebruikt [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5650","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Onderzoek toont aan dat gebruik van het artritismiddel Abatacept de ontwikkeling van Type 1 Diabetes (T1D) kan vertragen, tot een jaar nadat men is gestopt met het nemen van het middel. Het onderzoek werd uitgevoerd bijmensen die recent de diagnose T1D hadden gekregen. Zij namen het middel gedurende twee jaar in. Abatacept wordt nu gebruikt [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-10T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:42+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Middel tegen artritis vertraagt ontwikkeling T1D!\",\"datePublished\":\"2014-06-10T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\"},\"wordCount\":155,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\",\"name\":\"Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2014-06-10T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Middel tegen artritis vertraagt ontwikkeling T1D!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/","og_locale":"nl_NL","og_type":"article","og_title":"Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D","og_description":"Onderzoek toont aan dat gebruik van het artritismiddel Abatacept de ontwikkeling van Type 1 Diabetes (T1D) kan vertragen, tot een jaar nadat men is gestopt met het nemen van het middel. Het onderzoek werd uitgevoerd bijmensen die recent de diagnose T1D hadden gekregen. Zij namen het middel gedurende twee jaar in. Abatacept wordt nu gebruikt [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/","og_site_name":"Breakthrough T1D","article_published_time":"2014-06-10T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:42+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Middel tegen artritis vertraagt ontwikkeling T1D!","datePublished":"2014-06-10T09:00:00+00:00","dateModified":"2024-09-23T11:22:42+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/"},"wordCount":155,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/","name":"Middel tegen artritis vertraagt ontwikkeling T1D! - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2014-06-10T09:00:00+00:00","dateModified":"2024-09-23T11:22:42+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-artritis-vertraagt-ontwikkeling-t1d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Middel tegen artritis vertraagt ontwikkeling T1D!"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5650"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5650\/revisions"}],"predecessor-version":[{"id":7197,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5650\/revisions\/7197"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}